These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 30251864)
21. [Preparation of diclofenac sodium liposomes and its ocular pharmacokinetics]. Sun KX; Wang AP; Huang LJ; Liang RC; Liu K Yao Xue Xue Bao; 2006 Nov; 41(11):1094-8. PubMed ID: 17262954 [TBL] [Abstract][Full Text] [Related]
22. Biodegradable levofloxacin nanoparticles for sustained ocular drug delivery. Gupta H; Aqil M; Khar RK; Ali A; Bhatnagar A; Mittal G J Drug Target; 2011 Jul; 19(6):409-17. PubMed ID: 20678034 [TBL] [Abstract][Full Text] [Related]
23. A potential in situ gel formulation loaded with novel fabricated poly(lactide-co-glycolide) nanoparticles for enhancing and sustaining the ophthalmic delivery of ketoconazole. Ahmed TA; Aljaeid BM Int J Nanomedicine; 2017; 12():1863-1875. PubMed ID: 28331311 [TBL] [Abstract][Full Text] [Related]
24. Nanostructured lipid carriers as novel ophthalmic delivery system for mangiferin: improving in vivo ocular bioavailability. Liu R; Liu Z; Zhang C; Zhang B J Pharm Sci; 2012 Oct; 101(10):3833-44. PubMed ID: 22767401 [TBL] [Abstract][Full Text] [Related]
25. A novel ion-exchange carrier based upon liposome-encapsulated montmorillonite for ophthalmic delivery of betaxolol hydrochloride. Huang Y; Tao Q; Hou D; Hu S; Tian S; Chen Y; Gui R; Yang L; Wang Y Int J Nanomedicine; 2017; 12():1731-1745. PubMed ID: 28280338 [TBL] [Abstract][Full Text] [Related]
26. Hyalugel-integrated liposomes as a novel ocular nanosized delivery system of fluconazole with promising prolonged effect. Moustafa MA; Elnaggar YSR; El-Refaie WM; Abdallah OY Int J Pharm; 2017 Dec; 534(1-2):14-24. PubMed ID: 28987453 [TBL] [Abstract][Full Text] [Related]
27. Ocular surface distribution and pharmacokinetics of a novel ophthalmic 1% azithromycin formulation. Akpek EK; Vittitow J; Verhoeven RS; Brubaker K; Amar T; Powell KD; Boyer JL; Crean C J Ocul Pharmacol Ther; 2009 Oct; 25(5):433-9. PubMed ID: 19857105 [TBL] [Abstract][Full Text] [Related]
28. Liposome incorporated ion sensitive in situ gels for opthalmic delivery of timolol maleate. Yu S; Wang QM; Wang X; Liu D; Zhang W; Ye T; Yang X; Pan W Int J Pharm; 2015 Mar; 480(1-2):128-36. PubMed ID: 25615987 [TBL] [Abstract][Full Text] [Related]
30. Clarithromycin-loaded liposomes offering high drug loading and less irritation. Liu X; Sun W; Zhang B; Tian B; Tang X; Qi N; He H; Li H; Jin X Int J Pharm; 2013 Feb; 443(1-2):318-27. PubMed ID: 23337631 [TBL] [Abstract][Full Text] [Related]
31. Application of Box-Behnken design for preparation of levofloxacin-loaded stearic acid solid lipid nanoparticles for ocular delivery: Optimization, in vitro release, ocular tolerance, and antibacterial activity. Baig MS; Ahad A; Aslam M; Imam SS; Aqil M; Ali A Int J Biol Macromol; 2016 Apr; 85():258-70. PubMed ID: 26740466 [TBL] [Abstract][Full Text] [Related]
32. Mucin-targeting-aptamer functionalized liposomes for delivery of cyclosporin A for dry eye diseases. Wong KY; Liu Y; Zhou L; Wong MS; Liu J J Mater Chem B; 2023 May; 11(21):4684-4694. PubMed ID: 37161679 [TBL] [Abstract][Full Text] [Related]
33. Development of a topical polymeric mucoadhesive ocular delivery system for azithromycin. Bowman LM; Si E; Pang J; Archibald R; Friedlaender M J Ocul Pharmacol Ther; 2009 Apr; 25(2):133-9. PubMed ID: 19284320 [TBL] [Abstract][Full Text] [Related]
34. Fabrication and characterization of silk fibroin-coated liposomes for ocular drug delivery. Dong Y; Dong P; Huang D; Mei L; Xia Y; Wang Z; Pan X; Li G; Wu C Eur J Pharm Biopharm; 2015 Apr; 91():82-90. PubMed ID: 25643990 [TBL] [Abstract][Full Text] [Related]
35. Formulation and corneal permeation of ketorolac tromethamine-loaded chitosan nanoparticles. Fathalla ZM; Khaled KA; Hussein AK; Alany RG; Vangala A Drug Dev Ind Pharm; 2016; 42(4):514-24. PubMed ID: 26407208 [TBL] [Abstract][Full Text] [Related]
36. Comparison of in vivo efficacy of different ocular lubricants in dry eye animal models. Zheng X; Goto T; Ohashi Y Invest Ophthalmol Vis Sci; 2014 Apr; 55(6):3454-60. PubMed ID: 24781937 [TBL] [Abstract][Full Text] [Related]
37. Topical drug delivery to retinal pigment epithelium with microfluidizer produced small liposomes. Lajunen T; Hisazumi K; Kanazawa T; Okada H; Seta Y; Yliperttula M; Urtti A; Takashima Y Eur J Pharm Sci; 2014 Oct; 62():23-32. PubMed ID: 24810393 [TBL] [Abstract][Full Text] [Related]
38. Efficacy of azithromycin 1% ophthalmic solution for treatment of ocular surface disease from posterior blepharitis. Opitz DL; Tyler KF Clin Exp Optom; 2011 Mar; 94(2):200-6. PubMed ID: 21083761 [TBL] [Abstract][Full Text] [Related]
39. Formulation and In Vitro-Ex vivo Evaluation of Cannabidiol and Cannabidiol-Valine-Hemisuccinate Loaded Lipid-Based Nanoformulations for Ocular Applications. Adel Ali Youssef A; Hayder Abdelrahman M; Geweda MM; Varner C; Joshi PH; Ghonge M; Dudhipala N; Sulochana SP; Gadepalli RS; Majumdar S Int J Pharm; 2024 May; 657():124110. PubMed ID: 38604539 [TBL] [Abstract][Full Text] [Related]
40. Ocular amphotericin B delivery by chitosan-modified nanostructured lipid carriers for fungal keratitis-targeted therapy. Fu T; Yi J; Lv S; Zhang B J Liposome Res; 2017 Sep; 27(3):228-233. PubMed ID: 27601177 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]